- Home
- BRTX vs FMST Comparison
BRTX vs FMST Comparison
Compare BRTX & FMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRTX
- FMST
- Stock Information
- Founded
- BRTX 1997
- FMST 2005
- Country
- BRTX United States
- FMST Canada
- Employees
- BRTX N/A
- FMST N/A
- Industry
- BRTX Managed Health Care
- FMST Other Metals and Minerals
- Sector
- BRTX Health Care
- FMST Basic Materials
- Exchange
- BRTX Nasdaq
- FMST Nasdaq
- Market Cap
- BRTX 15.9M
- FMST 16.8M
- IPO Year
- BRTX N/A
- FMST N/A
- Fundamental
- Price
- BRTX $1.80
- FMST $0.99
- Analyst Decision
- BRTX Strong Buy
- FMST
- Analyst Count
- BRTX 1
- FMST 0
- Target Price
- BRTX $18.00
- FMST N/A
- AVG Volume (30 Days)
- BRTX 812.7K
- FMST 81.0K
- Earning Date
- BRTX 03-28-2025
- FMST 01-01-0001
- Dividend Yield
- BRTX N/A
- FMST N/A
- EPS Growth
- BRTX N/A
- FMST N/A
- EPS
- BRTX N/A
- FMST N/A
- Revenue
- BRTX $377,000.00
- FMST N/A
- Revenue This Year
- BRTX $482.76
- FMST N/A
- Revenue Next Year
- BRTX $212.24
- FMST N/A
- P/E Ratio
- BRTX N/A
- FMST N/A
- Revenue Growth
- BRTX 189.55
- FMST N/A
- 52 Week Low
- BRTX $1.03
- FMST $0.89
- 52 Week High
- BRTX $2.55
- FMST $3.50
- Technical
- Relative Strength Index (RSI)
- BRTX 37.55
- FMST 39.18
- Support Level
- BRTX $2.26
- FMST $0.89
- Resistance Level
- BRTX $2.38
- FMST $1.14
- Average True Range (ATR)
- BRTX 0.22
- FMST 0.15
- MACD
- BRTX -0.09
- FMST -0.00
- Stochastic Oscillator
- BRTX 7.98
- FMST 24.36
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.
About FMST Foremost Lithium Resource & Technology Ltd. Common stock
Foremost Clean Energy Ltd is an emerging North American uranium and lithium exploration company. Its uranium portfolio consists of projects at different stages of exploration from grassroots, to those with significant historical exploration and drill-ready targets. It also maintains a secondary portfolio of lithium projects at different stages of development spanning 50,000-plus acres across Manitoba and Quebec.